Fuda Cancer Hospital
Chondrosarcoma treatment cost in China typically relies on a combination of surgical intervention and advanced radiation. A major surgical procedure such as bone resection runs from $9,500 to $22,500, while specialized proton therapy runs from $36,500 to $47,500. Total expenses depend on the tumor stage, surgical complexity, and specific technology used. Patients often save 45% to 85% compared to US medical costs in cities like Guangzhou, Beijing, and Xiamen.
Typical Chondrosarcoma Treatment Costs in China
Bookimed Expert Insight: Advanced stage patients benefit from centers specializing in minimally invasive technologies. Fuda Cancer Hospital offers specialized cryosurgery and NanoKnife therapies, treating over 30,000 international patients. For cases requiring complex multidisciplinary management, Xiamen Humanity Hospital provides comprehensive tertiary care with 47 clinical departments. Those needing high-precision radiation should consider specialists like Professor Liu Shi Xin. He is an expert in VMAT and SBRT at JCI-accredited facilities.
| China | Turkey | Austria | |
| Proton-beam therapy | from $36,500 | from $70,000 | from $80,000 |
| Proton therapy for prostate cancer | from $42,500 | from $30,000 | from $80,000 |
| Proton therapy for breast cancer | from $38,500 | from $30,000 | from $55,000 |
| Chemotherapy for breast cancer | from $14,800 | from $1,200 | from $15,000 |
| Bone resection | from $9,500 | from $8,000 | from $25,000 |
Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.
He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.
His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.
The doctor is a renowned expert in minimally invasive cryosurgery for cancer, serving as President and chief surgeon at Fuda Cancer Hospital since 2001. With a focus on oncology and minimally invasive procedures, the doctor has performed nearly 10,000 cryosurgeries and 500 NanoKnife procedures, treating patients aged 4 to 94.
Graduating from The Fourth Military Medical University with a specialty in thoracic and cardiac surgery, the doctor has contributed significantly to the field with over 100 published papers. Recognized with awards for outstanding contributions to cryosurgery, the doctor holds vice-presidential roles in both the Asian and International Societies of Cryosurgery.